"The ESH 4th Translational Research Conference on Acute Lymphoblastic Leukaemia will welcome an outstanding faculty of global authorities for a scientific programme that is designed to integrate leading-edge basic, clinical and therapeutic advances, and new perspectives.
Chairs: Kathrin Bernt, Jan Cools, Hervé Dombret, Ulla Wartiovaara-Kautto"
"ESH Translational Research Conference programmes are designed to place emphasis on lleading-edge basic, clinical and therapeutic research and future perspectives. Ample time is deliberately provided for in-depth scientific discussion and interaction. Registered participants further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in their field, including during small Meet the Expert sessions and Mentored Posters Walks. ESH conference delegates are invited to submit abstracts. Selected abstracts are presented as brief oral communications or posters.
The presentation of unpublished data is encouraged.
Continuing Medical Education (CME) credit points will be awarded to physicians for the time they will spend at the meeting improving their knowledge and skills. ESH is a provider of the European Hematology CME system."
Posters and Brief Oral Communications:
Registered participants are invited to submit their Biology and Clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.
Call for abstracts: deadline FEBRUARY 23rd, 2025 (23:59 CET)
This meeting will be valuable to you if you are looking for:
• A cutting-edge scientific programme – from basic science to clinical and therapeutic applications and perspectives
• Multiple opportunities for scientific interaction with an international faculty of distinguished experts
• An emphasis on critical discussion
The meeting will provide clinicians and scientists with state-of-the-art recommendations regarding patient care and insight in controversies in the field.
The meeting will be of interest to:
• Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
• Junior scientists and clinicians (MD, PhD)
• PhD candidates and clinical residents still in-training
Scientific Topics:
- The biology of T-ALL
- The biology of B-cell precursor ALL subtypes
- Specific genetic entities
- Host factors
- Measurable Residual Disease (MRD)
- Targeted therapy
- Immunotherapy
- Cell therapy
The programme will include:
– Plenary Sessions
– Panel Discussions
– Debates
– Poster Walks
– Meet the Expert Sessions
– Keynote lectures
To register for this event follow this link: https://www.esh.org/conference/4th-translational-research-conference-acute-lymphoblastic-leukaemia/
For questions about the event please contact: [email protected]
